203 related articles for article (PubMed ID: 26953320)
1. DNA methylation profiling in human Huntington's disease brain.
De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR
Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional Regulation of the Huntingtin Gene.
Thomson SB; Leavitt BR
J Huntingtons Dis; 2018; 7(4):289-296. PubMed ID: 30452421
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
4. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity.
Pan Y; Zhu Y; Yang W; Tycksen E; Liu S; Palucki J; Zhu L; Sasaki Y; Sharma MK; Kim AH; Zhang B; Yano H
J Biol Chem; 2018 Jul; 293(30):11850-11866. PubMed ID: 29891550
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
Bithell A; Johnson R; Buckley NJ
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
7. Huntington's Disease Protein Huntingtin Associates with its own mRNA.
Culver BP; DeClercq J; Dolgalev I; Yu MS; Ma B; Heguy A; Tanese N
J Huntingtons Dis; 2016; 5(1):39-51. PubMed ID: 26891106
[TBL] [Abstract][Full Text] [Related]
8. Computational Analysis of Transcriptional Regulation Sites at the HTT Gene Locus.
De Souza RAG; Kosior N; Thomson SB; Mathelier A; Zhang AW; Bečanović K; Wasserman WW; Leavitt BR
J Huntingtons Dis; 2018; 7(3):223-237. PubMed ID: 30103339
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation study of Huntington's disease and motor progression in patients and in animal models.
Lu AT; Narayan P; Grant MJ; Langfelder P; Wang N; Kwak S; Wilkinson H; Chen RZ; Chen J; Simon Bawden C; Rudiger SR; Ciosi M; Chatzi A; Maxwell A; Hore TA; Aaronson J; Rosinski J; Preiss A; Vogt TF; Coppola G; Monckton D; Snell RG; William Yang X; Horvath S
Nat Commun; 2020 Sep; 11(1):4529. PubMed ID: 32913184
[TBL] [Abstract][Full Text] [Related]
10. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal instability during neurogenesis in Huntington's disease.
Ruzo A; Croft GF; Metzger JJ; Galgoczi S; Gerber LJ; Pellegrini C; Wang H; Fenner M; Tse S; Marks A; Nchako C; Brivanlou AH
Development; 2018 Jan; 145(2):. PubMed ID: 29378824
[TBL] [Abstract][Full Text] [Related]
14. Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.
Ratovitski T; Jiang M; O'Meally RN; Rauniyar P; Chighladze E; Faragó A; Kamath SV; Jin J; Shevelkin AV; Cole RN; Ross CA
Hum Mol Genet; 2022 May; 31(10):1651-1672. PubMed ID: 34888656
[TBL] [Abstract][Full Text] [Related]
15. DNA Methylation in Huntington's Disease.
Zsindely N; Siági F; Bodai L
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884540
[TBL] [Abstract][Full Text] [Related]
16. A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.
Bečanović K; Nørremølle A; Neal SJ; Kay C; Collins JA; Arenillas D; Lilja T; Gaudenzi G; Manoharan S; Doty CN; Beck J; Lahiri N; Portales-Casamar E; Warby SC; Connolly C; De Souza RA; ; Tabrizi SJ; Hermanson O; Langbehn DR; Hayden MR; Wasserman WW; Leavitt BR
Nat Neurosci; 2015 Jun; 18(6):807-16. PubMed ID: 25938884
[TBL] [Abstract][Full Text] [Related]
17. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington's disease models.
Conforti P; Zuccato C; Gaudenzi G; Ieraci A; Camnasio S; Buckley NJ; Mutti C; Cotelli F; Contini A; Cattaneo E
J Neurochem; 2013 Oct; 127(1):22-35. PubMed ID: 23800350
[TBL] [Abstract][Full Text] [Related]
18. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation in Huntington's disease.
Hyeon JW; Kim AH; Yano H
Neurochem Int; 2021 Sep; 148():105074. PubMed ID: 34038804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
